scholarly journals OP014. A multicentre, double-blind, placebo-controlled phase 3 study of ustekinumab, a human interleukins-12/23p40 mab, in moderate-severe Crohn’s disease refractory to anti-tumour necrosis factor α: UNITI-1

2016 ◽  
Vol 10 (suppl 1) ◽  
pp. S11-S12 ◽  
2010 ◽  
Vol 192 (7) ◽  
pp. 375-377 ◽  
Author(s):  
Daniel C Burger ◽  
Ian C Lawrance ◽  
Peter A Bampton ◽  
Ruth Prosser ◽  
Anthony Croft ◽  
...  

2009 ◽  
Vol 11 (11) ◽  
pp. 1106-1109 ◽  
Author(s):  
Maximilian Y. Emmert ◽  
Sacha P. Salzberg ◽  
Lorenz S. Emmert ◽  
Sohil Behjati ◽  
Andre Plass ◽  
...  

2016 ◽  
Vol 48 (10) ◽  
pp. 1168-1171 ◽  
Author(s):  
Piotr Eder ◽  
Katarzyna Korybalska ◽  
Liliana Łykowska-Szuber ◽  
Kamila Stawczyk-Eder ◽  
Iwona Krela-Kaźmierczak ◽  
...  

2018 ◽  
Vol 30 (10) ◽  
pp. 1155-1158
Author(s):  
Sandra Bohn Thomsen ◽  
Marianne Kiszka-Kanowitz ◽  
Klaus Theede ◽  
Lise Lotte Gluud ◽  
Anette Mertz Nielsen

Sign in / Sign up

Export Citation Format

Share Document